| 注册
首页|期刊导航|中国药房|阿折地平片在中国健康人体内的药动学研究

阿折地平片在中国健康人体内的药动学研究

陈燕 林阳 韩敏 李静 聂晓敏 段鹏 周子杰 汪柯

中国药房2011,Vol.22Issue(38):3585-3588,4.
中国药房2011,Vol.22Issue(38):3585-3588,4.

阿折地平片在中国健康人体内的药动学研究

Study on Pharmacokinetics of Azelnidipine Tablets in Chinese Healthy Volunteers

陈燕 1林阳 1韩敏 1李静 1聂晓敏 1段鹏 1周子杰 1汪柯1

作者信息

  • 1. 首都医科大学附属北京安贞医院,北京市100029
  • 折叠

摘要

Abstract

OBJECTIVE: To investigate the pharmacokinetic characteristics of Azelnidipine tablets in Chinese healthy volunteers. METHODS: 20 healthy volunteers(10 for male, 10 for female) were randomly divided into two dosage groups and received oral dose of Azelnidipine tablets 8 or 16 mg, respectively. The blood concentration of azelnidipine was determined by LC-MS and the pharmacokinetic parameters were calculated using DAS2.1.1 software. RESULTS: Main pharmacokinetic parameters of azelnidipine in health volunteers after the single and multiple oral dose of 8 mg were as follows: f_(2.6 ± 0.6)h and(2.8 ± 0.9)h;c?(4.16 ± 1.86) ug-L~' and (6.62±2.23)ug·L-1;t1/2β(23.0±6.8)h and (25.5±9.5)h;AUCo~96 h(44.1 ± 19.6)ug·h-L-1 and (113±67.0)ug·h·L-1; accumulative ratio: 1.90 ± 1.20; range of motion: 1.85 ±0.49. No significant differences existed in 4 trough concentrations of multiple doses administration (P=0.058). The pharmacokinetic parameters of azelnidipine in health volunteers after the single oral dose of 16 mg were asfollows:fmax(2.7±0.6)h,cmax(10.6±5.4)ug·L-1, tl/2β(25.2± 13.8)h, CL/F(80.5±50.4)L·h-1, V,/F(706±511)L, AUG0-96h(132± 76)ug-h-L"'. Pharmacokinetic parameters of single dose were consistent with those of multiple dose, no gender difference was found. The dosage of the trial was safe and no severe ADR of azelnidipine occurred. CONCLUSION: The method is sensitive, accurate and simple, and it provides reference for clinical drug use.

关键词

阿折地平/液-质联用法/药动学

Key words

Azelnidipine/ LC-MS/ Pharmacokinetics

分类

医药卫生

引用本文复制引用

陈燕,林阳,韩敏,李静,聂晓敏,段鹏,周子杰,汪柯..阿折地平片在中国健康人体内的药动学研究[J].中国药房,2011,22(38):3585-3588,4.

中国药房

OACSCDCSTPCD

1001-0408

访问量0
|
下载量0
段落导航相关论文